Last Updated: Thursday, November 12, 2015
A new drug being studied, CM-AT, is based on Curemark’s recent research that showed enzyme deficiencies in some autistic children result in an inability to digest protein. The inability to digest protein affects the production of amino acids, the building blocks of chemicals essential for brain function.
The study involves 9 visits over 12 weeks. Visits may include questionnaires, stool samples, or physical exams at no cost to you.
Your time will be compensated.
Sponsored by Curemark.
Children age 3– 8 with autism spectrum disorder
Evaluations, study visits, and study drug are provided at no cost. $50 per site visit will be provided.
Up to 9 visits to Vanderbilt University
615 936 3288
To be notified when you are a possible match for a research study looking for participants, register with Vanderbilt's ResearchMatch at the link below.
ResearchMatch.org is a free and safe national website
that matches research volunteers with researchers looking for participants. Registries for Autism and Intellectual Disabilities are now
available on ResearchMatch. Everyone is welcome to join, regardless of age, or condition.
Visit www.researchmatch.org to learn more and to join today.